Macrophage activation by an ornithine-containing lipid or a serine-containing lipid.

Y Kawai, K Akagawa
Author Information
  1. Y Kawai: Department of Bacteriology, National Institute of Health, Tokyo, Japan.

Abstract

alpha-N-(3-Acyloxyacyl)-ornithine (or -serine) is the structure of lipoamino acids obtained by us previously from some gram-negative bacteria (Y. Kawai and I. Yano, Eur. J. Biochem. 136:531-538, 1983; Y. Kawai, I. Yano, and K. Kaneda, Eur. J. Biochem. 171:73-80, 1988; Y. Kawai, I. Yano, K. Kaneda, and E. Yabuuchi, Eur. J. Biochem. 175:633-641, 1988). The 3-acyloxyacylamide structure is present in both the lipoamino acids and lipid A of lipopolysaccharide (endotoxin). The efficacy of lipoamino acids (an ornithine-containing lipid and a serine-containing lipid) in activating C3H/HeSlc mouse peritoneal exudate macrophages was compared with that of bacterial lipopolysaccharide, because the two types of substances were expected to exhibit similar biological activities and physiological functions on the basis of their structural similarities. Actually, the lipoamino acids, as well as lipopolysaccharide, strongly activated the macrophages to generate the immunoregulatory substances prostaglandin E2 and interleukin-1, but their effect on the induction of L929 cell cytolytic factor (a possible tumor necrosis factor), another immunoregulatory substance, was weaker than that of lipopolysaccharide. The effect of lipoamino acids on the cytotoxicity of macrophages for EL-4 leukemia cells was very weak. However, all of these activities, as far as tested, were strongly enhanced by synergistic action with gamma interferon. Only the serine-containing lipid killed both C3H/HeSlc and C3H/HeJ macrophages to almost the same degree as endotoxin killed C3H/HeSlc macrophages. On the other hand, lethal toxicity for mice was not found with either the ornithine-containing lipid or the serine-containing lipid, even when 7 mg of compound was injected into a mouse. These studies suggest that the lipoamino acids are nontoxic characteristic immunoactivators.

References

  1. Eur J Biochem. 1983 Nov 15;136(3):531-8 [PMID: 6315433]
  2. Rev Infect Dis. 1983 Sep-Oct;5 Suppl 4:S733-47 [PMID: 6195718]
  3. N Engl J Med. 1984 Nov 29;311(22):1413-8 [PMID: 6208485]
  4. Proc Natl Acad Sci U S A. 1985 Jan;82(2):282-6 [PMID: 3881760]
  5. Eur J Biochem. 1985 Mar 1;147(2):367-70 [PMID: 3971986]
  6. Eur J Biochem. 1985 Apr 1;148(1):1-5 [PMID: 2579812]
  7. Br J Cancer. 1985 May;51(5):739-42 [PMID: 3888244]
  8. Infect Immun. 1985 Jul;49(1):225-37 [PMID: 3891627]
  9. Science. 1985 Nov 8;230(4726):630-2 [PMID: 2413547]
  10. J Exp Med. 1985 Nov 1;162(5):1444-59 [PMID: 2414387]
  11. Nature. 1986 Apr 17-23;320(6063):584-8 [PMID: 3010124]
  12. Science. 1986 May 23;232(4753):977-80 [PMID: 3754653]
  13. Dev Biol Stand. 1985;61:249-54 [PMID: 2872110]
  14. Infect Immun. 1986 Jun;52(3):905-7 [PMID: 3519466]
  15. J Clin Invest. 1987 Feb;79(2):319-26 [PMID: 3543052]
  16. N Engl J Med. 1987 Feb 12;316(7):379-85 [PMID: 3543677]
  17. Jpn J Cancer Res. 1987 Mar;78(3):279-87 [PMID: 3106284]
  18. Infect Immun. 1987 Jul;55(7):1622-5 [PMID: 3596805]
  19. Infect Immun. 1988 Jan;56(1):149-55 [PMID: 3257202]
  20. Eur J Biochem. 1988 Jan 15;171(1-2):73-80 [PMID: 3123236]
  21. J Biol Chem. 1988 Apr 15;263(11):5098-103 [PMID: 3128535]
  22. Eur J Biochem. 1988 Aug 15;175(3):573-80 [PMID: 3044789]
  23. Eur J Biochem. 1988 Aug 15;175(3):633-41 [PMID: 3409887]
  24. J Biol Chem. 1972 Jan 10;247(1):170-8 [PMID: 4552922]
  25. J Immunol. 1977 Jul;119(1):162-6 [PMID: 326955]
  26. J Biochem. 1977 May;81(5):1567-9 [PMID: 19439]
  27. J Immunol. 1978 May;120(5):1497-503 [PMID: 149171]
  28. Eur J Biochem. 1980 Apr;105(2):267-74 [PMID: 7379785]
  29. FEBS Lett. 1980 Nov 3;120(2):217-20 [PMID: 7002614]
  30. J Bacteriol. 1982 Aug;151(2):996-1005 [PMID: 6284719]
  31. Scand J Infect Dis Suppl. 1982;31:8-21 [PMID: 7048515]
  32. J Bacteriol. 1982 Nov;152(2):907-10 [PMID: 6290456]
  33. Microbiol Immunol. 1982;26(9):831-42 [PMID: 7154991]
  34. FEBS Lett. 1983 Mar 7;153(1):131-3 [PMID: 6825855]
  35. Proc Natl Acad Sci U S A. 1983 Aug;80(15):4624-8 [PMID: 6348772]
  36. J Immunol. 1983 Nov;131(5):2362-7 [PMID: 6415164]
  37. Infect Immun. 1984 May;44(2):421-6 [PMID: 6715042]

MeSH Term

Animals
Cytotoxicity, Immunologic
Dinoprostone
Interleukin-1
Killer Factors, Yeast
L Cells
Lipid A
Lipids
Macrophage Activation
Macrophages
Mice
Mice, Inbred C3H
Mice, Inbred ICR
Ornithine
Protein Biosynthesis
Proteins
Serine

Chemicals

Interleukin-1
Killer Factors, Yeast
Lipid A
Lipids
Proteins
ornithine containing aminolipid
Serine
Ornithine
Dinoprostone

Word Cloud

Created with Highcharts 10.0.0lipidlipoaminoacidsmacrophageslipopolysaccharideserine-containingYKawaiYanoEurJBiochemornithine-containingC3H/HeSlcstructureKKaneda1988endotoxinmousesubstancesactivitiesstronglyimmunoregulatoryeffectfactorkilledalpha-N-3-Acyloxyacyl-ornithine-serineobtaineduspreviouslygram-negativebacteria136:531-5381983171:73-80EYabuuchi175:633-6413-acyloxyacylamidepresentefficacyactivatingperitonealexudatecomparedbacterialtwotypesexpectedexhibitsimilarbiologicalphysiologicalfunctionsbasisstructuralsimilaritiesActuallywellactivatedgenerateprostaglandinE2interleukin-1inductionL929cellcytolyticpossibletumornecrosisanothersubstanceweakercytotoxicityEL-4leukemiacellsweakHoweverfartestedenhancedsynergisticactiongammainterferonC3H/HeJalmostdegreehandlethaltoxicitymicefoundeithereven7mgcompoundinjectedstudiessuggestnontoxiccharacteristicimmunoactivatorsMacrophageactivation

Similar Articles

Cited By